New Taiwan study contradicts earlier findings on Metformin’s neurodegenerative disease protective effect

By Dave Silver
March 31, 2017
A Taiwanese study presented yesterday at an international conference on Alzheimer’s and Parkinson’s diseases suggested that long-term use of the popular diabetes medication Metformin may increase the risk of neurodegenerative disease in patients with type 2 diabetes mellitus, contradicting the results of a large study published just last year following US-based subjects that seemed to show that Metformin exerts a protective effect against the same diseases.

Read more